Table 6.
Daily dose of omeprazole | ||||
---|---|---|---|---|
Total (N = 7711) |
10 mg (N = 2956) |
20 mg (N = 4726) |
40 mg2) (N = 29) |
|
No. of patients with adverse drug reactions | 71 | 26 | 45 | 0 |
No. of adverse drug reactions | 73 | 28 | 45 | 0 |
Rate of adverse drug reactions | 0.92% | 0.88% | 0.95% | 0% |
Preferred term3) | ||||
Diarrhoea | 7 (0.09) | 3 (0.10) | 4 (0.08) | 0 |
Abdominal distension | 5 (0.06) | 2 (0.07) | 3 (0.06) | 0 |
Drug eruption | 5 (0.06) | 1 (0.03) | 4 (0.08) | 0 |
Thirst | 5 (0.06) | 1 (0.03) | 4 (0.08) | 0 |
Pruritus | 4 (0.05) | 2 (0.07) | 2 (0.04) | 0 |
Upper abdominal pain | 3 (0.04) | 0 | 3 (0.06) | 0 |
Constipation | 3 (0.04) | 1 (0.03) | 2 (0.04) | 0 |
Vomiting | 3 (0.04) | 1 (0.03) | 2 (0.04) | 0 |
Eczema | 3 (0.04) | 1 (0.03) | 2 (0.04) | 0 |
Rash | 3 (0.04) | 1 (0.03) | 2 (0.04) | 0 |
Abnormal hepatic function | 2 (0.03) | 0 | 2 (0.04) | 0 |
Muscle pains | 2 (0.03) | 1 (0.03) | 1 (0.02) | 0 |
Values are n (%).
1) Some patients have more than one adverse drug reaction; events occurred in two or more patients are listed.
2) 20 mg twice daily.
3) MedDRA Ver12.0.